You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,233,285


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,233,285
Title: Mercaptocarboxylic acid radiopharmaceuticals
Abstract:Mercaptocarboxylic acid chelated heavy metal radioisotope pharmaceuticals and methods for making them.
Inventor(s): Winchell; Harry S. (Lafayette, CA), Lin; Tz-Hong (Berkeley, CA)
Assignee: Medi-Physics, Inc. (Emeryville, CA)
Application Number:05/359,719
Patent Claim Types:
see list of patent claims
Compound; Formulation; Composition; Use; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 4,233,285

Introduction

United States Patent 4,233,285, though not specifically detailed in the provided sources, can be analyzed within the broader context of patent law, claims, and the patent landscape in the United States. Here, we will delve into the general principles and processes that apply to patents, including the scope, claims, and relevant legal frameworks.

Patent Scope and Claims

Definition and Importance

Patent scope and claims are crucial elements of a patent application. The scope defines the breadth of protection granted to the inventor, while the claims are the specific statements that define the invention and its boundaries[3].

Types of Claims

Patents can include various types of claims, such as independent claims, dependent claims, and method claims. Independent claims stand alone and define the invention without reference to other claims, while dependent claims refer back to and further limit an independent claim. Method claims describe a process or method of achieving a particular result[3].

Patent Landscape in the United States

Historical Context

The U.S. patent system has evolved significantly over the years. Patents granted between 1976 and 2014, for example, show a trend in increasing complexity and specificity in claims. The USPTO's Patent Claims Research Dataset provides detailed information on these trends, including claim-level statistics and document-level statistics[3].

Current Trends

The probability of receiving a U.S. patent has decreased over time, particularly in fields like drugs and medical instruments, and computers and communications. Only about 55.8% of patent applications filed between 1996 and mid-2013 were granted without using continuation procedures[4].

Legal Frameworks

Obviousness-Type Double Patenting (ODP)

ODP is a critical concept in patent law that prevents the same inventor from obtaining multiple patents for the same invention. This was highlighted in the case of In re Cellect, where multiple patents were invalidated due to ODP, emphasizing the importance of ensuring that each patent in a family of patents does not claim the same invention[1].

Patent Eligibility Under 35 U.S.C. § 101

Patent eligibility is a key issue, as seen in Mobile Acuity Ltd. v. Blippar Ltd. The Supreme Court's two-step framework for determining patent eligibility involves identifying whether the claims are directed to patent-ineligible concepts (such as abstract ideas) and then searching for an inventive concept that ensures the patent is more than just the ineligible concept itself[2].

Analyzing Patent Claims

Dependency and Scope

Claims can be dependent or independent, and their dependency relationships are crucial for understanding the patent's scope. The USPTO's dataset on patent claims helps in analyzing these relationships and measuring the scope of patents[3].

Statistical Analysis

Statistical analysis of patent claims can provide insights into the trends and characteristics of patents. For instance, the USPTO's dataset includes claim-level statistics and document-level statistics, which can be used to understand the complexity and breadth of patent claims[3].

Practical Considerations

Prosecution Histories

Understanding the prosecution histories of patent applications is vital. This includes tracking the allowances, abandonments, and continuations of applications, which can provide insights into the likelihood of a patent being granted and the challenges that may arise during the process[4].

Small Claims Patent Court

There is ongoing discussion about the feasibility of a small claims patent court, which could simplify and reduce the costs associated with patent litigation. This initiative involves considering legal, policy, and practical aspects to ensure that such a court would be effective and fair for all stakeholders[5].

Case Studies and Examples

In re Cellect

The In re Cellect case illustrates the complexities of ODP and the importance of ensuring that each patent in a family does not claim the same invention. This case involved multiple patents that were invalidated due to ODP, highlighting the need for careful analysis of patent claims and their relationships[1].

Mobile Acuity Ltd. v. Blippar Ltd.

The Mobile Acuity Ltd. v. Blippar Ltd. case demonstrates the application of the two-step framework for determining patent eligibility under 35 U.S.C. § 101. The court's decision to invalidate claims directed to abstract ideas without an inventive concept underscores the importance of ensuring that patents claim more than just ineligible concepts[2].

Key Takeaways

  • Patent Scope and Claims: The scope and claims of a patent are critical for defining the invention and its boundaries.
  • Legal Frameworks: Understanding ODP and patent eligibility under 35 U.S.C. § 101 is essential for ensuring the validity of patents.
  • Statistical Analysis: Analyzing patent claims statistically can provide valuable insights into trends and characteristics.
  • Practical Considerations: Prosecution histories and the potential for a small claims patent court are important practical aspects to consider.
  • Case Studies: Cases like In re Cellect and Mobile Acuity Ltd. v. Blippar Ltd. highlight key legal and procedural issues in patent law.

FAQs

  1. What is the significance of Obviousness-Type Double Patenting (ODP) in patent law? ODP prevents the same inventor from obtaining multiple patents for the same invention, ensuring that each patent in a family of patents does not claim the same invention.

  2. How does the Supreme Court determine patent eligibility under 35 U.S.C. § 101? The Supreme Court uses a two-step framework: first, identifying whether the claims are directed to patent-ineligible concepts, and then searching for an inventive concept that ensures the patent is more than just the ineligible concept itself.

  3. What is the purpose of the USPTO's Patent Claims Research Dataset? The dataset provides detailed information on claims from U.S. patents and applications, including claim-level statistics and document-level statistics, to help analyze trends and characteristics of patent claims.

  4. Why is the probability of receiving a U.S. patent decreasing? The probability has decreased over time, particularly in certain fields, due to stricter examination processes and the increasing complexity of inventions.

  5. What is the proposed role of a small claims patent court? A small claims patent court is proposed to simplify and reduce the costs associated with patent litigation, making it more accessible and efficient for all stakeholders.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1]
  2. Mobile Acuity Ltd. v. Blippar Ltd. - United States Court of Appeals for the Federal Circuit[2]
  3. Patent Claims Research Dataset - USPTO[3]
  4. What Is the Probability of Receiving a US Patent? - Yale Journal of Law & Technology[4]
  5. U.S. Patent Small Claims Court - Administrative Conference of the United States[5]

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,233,285

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.